Evangelische Krankenhaus Hamm
About Evangelische Krankenhaus Hamm
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Ulm
6
German CLL Study Group
5
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
EMD Serono Research & Development Institute, Inc.
2
Goethe University
2
Hoffmann-La Roche
2
Ipsen
2
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
Celgene
1
Daiichi Sankyo, Inc.
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Clinical Trials at Evangelische Krankenhaus Hamm
During the past decade, Evangelische Krankenhaus Hamm conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on
average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer
1999-07-01
Completed
430
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
1997-05-01
2002-02-01
Completed
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
2001-07-01
Unknown status
220
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine
2002-09-01
2009-08-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Evangelische Krankenhaus Hamm" #1 sponsor was "University of Ulm" with 6 trials, followed by "German CLL Study Group" with 5 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored and "Goethe University"
with 2 trials sponsored. Other sponsors include 17 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelische Krankenhaus Hamm"
#1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Evangelische Krankenhaus Hamm
According to Clinical.Site data, the most researched conditions in "Evangelische Krankenhaus Hamm" are
"Acute Myeloid Leukemia" (7 trials), "Leukemia" (6 trials), "Lymphoma" (5 trials), "Acute Myeloid Leukemia (AML)" (3 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Evangelische Krankenhaus Hamm" in a lesser frequency.
Clinical Trials Intervention Types at Evangelische Krankenhaus Hamm
Most popular intervention types in "Evangelische Krankenhaus Hamm" are "Drug" (34 trials), "Biological" (13 trials), "Radiation" (5 trials), "Other" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (7 trials), "vincristine sulfate" (6 trials), "doxorubicin hydrochloride" (5 trials), "filgrastim" (5 trials) and "radiation therapy" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Evangelische Krankenhaus Hamm
The vast majority of trials in "Evangelische Krankenhaus Hamm" are
41 trials for "All" genders.
Clinical Trials Status at Evangelische Krankenhaus Hamm
Currently, there are NaN active trials in "Evangelische Krankenhaus Hamm".
undefined are not yet recruiting,
9 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in Evangelische Krankenhaus Hamm,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Evangelische Krankenhaus Hamm, 1 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".